204 related articles for article (PubMed ID: 26927663)
1. Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis.
Rajamanickam S; Panneerdoss S; Gorthi A; Timilsina S; Onyeagucha B; Kovalskyy D; Ivanov D; Hanes MA; Vadlamudi RK; Chen Y; Bishop AJ; Arbiser JL; Rao MK
Clin Cancer Res; 2016 Jul; 22(14):3524-36. PubMed ID: 26927663
[TBL] [Abstract][Full Text] [Related]
2. The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events.
Timilsina S; Rajamanickam S; Rao A; Subbarayalu P; Nirzhor S; Abdelfattah N; Viswanadhapalli S; Chen Y; Jatoi I; Brenner A; Rao MK; Vadlamudi R; Kaklamani V
Cancer Lett; 2022 Aug; 540():215717. PubMed ID: 35568265
[TBL] [Abstract][Full Text] [Related]
3. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
8. Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.
Pal S; Kozono D; Yang X; Fendler W; Fitts W; Ni J; Alberta JA; Zhao J; Liu KX; Bian J; Truffaux N; Weiss WA; Resnick AC; Bandopadhayay P; Ligon KL; DuBois SG; Mueller S; Chowdhury D; Haas-Kogan DA
Cancer Res; 2018 Jul; 78(14):4007-4021. PubMed ID: 29760046
[TBL] [Abstract][Full Text] [Related]
9. The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3.
Zhang Z; Bu H; Yu J; Chen Y; Pei C; Yu L; Huang X; Tan G; Tan Y
Theranostics; 2019; 9(10):2882-2896. PubMed ID: 31244930
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks.
Shirode AB; Kovvuru P; Chittur SV; Henning SM; Heber D; Reliene R
Mol Carcinog; 2014 Jun; 53(6):458-70. PubMed ID: 23359482
[TBL] [Abstract][Full Text] [Related]
11. Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer.
Francica P; Nisa L; Aebersold DM; Langer R; Bladt F; Blaukat A; Stroka D; Martínez MR; Zimmer Y; Medová M
Clin Cancer Res; 2016 Nov; 22(21):5322-5336. PubMed ID: 27185371
[TBL] [Abstract][Full Text] [Related]
12. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW
Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.
Yuan F; Wang W
Mol Med Rep; 2015 Sep; 12(3):4647-4651. PubMed ID: 26080894
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
Yang C; Chen H; Yu L; Shan L; Xie L; Hu J; Chen T; Tan Y
Cancer Gene Ther; 2013 Feb; 20(2):117-24. PubMed ID: 23306612
[TBL] [Abstract][Full Text] [Related]
16. Mistletoe Extract Targets the STAT3-FOXM1 Pathway to Induce Apoptosis and Inhibits Metastasis in Breast Cancer Cells.
Kwon YS; Chun SY; Kim MK; Nan HY; Lee C; Kim S
Am J Chin Med; 2021; 49(2):487-504. PubMed ID: 33622211
[TBL] [Abstract][Full Text] [Related]
17. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
18. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1.
Kwon YS; Lee MG; Baek J; Kim NY; Jang H; Kim S
Biochem Pharmacol; 2021 Oct; 192():114718. PubMed ID: 34358518
[TBL] [Abstract][Full Text] [Related]
19. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
20. Roles of FoxM1 in cell regulation and breast cancer targeting therapy.
Song X; Fiati Kenston SS; Zhao J; Yang D; Gu Y
Med Oncol; 2017 Mar; 34(3):41. PubMed ID: 28176242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
